Page last updated: 2024-09-05

enzastaurin and bryostatin 1

enzastaurin has been researched along with bryostatin 1 in 1 studies

Compound Research Comparison

Studies (enzastaurin)	Trials (enzastaurin)	Recent Studies (post-2010) (enzastaurin)	Studies (bryostatin 1)	Trials (bryostatin 1)	Recent Studies (post-2010) (bryostatin 1)
188	52	99	727	46	174

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gonelli, A; Guerrini, R; Mischiati, C; Salvadori, S; Voltan, R; Zauli, G	1

Reviews

1 review(s) available for enzastaurin and bryostatin 1

Article	Year
Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents. Mini reviews in medicinal chemistry, 2009, Volume: 9, Issue:4 Topics: Animals; Antineoplastic Agents; Apoptosis; Bryostatins; Cell Cycle; Cell Transformation, Neoplastic; Clinical Trials as Topic; Humans; Indoles; Neoplasm Metastasis; Neovascularization, Pathologic; Plant Extracts; Protein Kinase C-delta; Protein Kinase C-epsilon; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53	2009

Article

Year

Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents.

Mini reviews in medicinal chemistry, 2009, Volume: 9, Issue:4

Topics: Animals; Antineoplastic Agents; Apoptosis; Bryostatins; Cell Cycle; Cell Transformation, Neoplastic; Clinical Trials as Topic; Humans; Indoles; Neoplasm Metastasis; Neovascularization, Pathologic; Plant Extracts; Protein Kinase C-delta; Protein Kinase C-epsilon; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53

2009